Abstract: A glass material that includes: from about 0.45 to about 0.86 mole fraction of SiO2; from about 0.05 to about 0.43 mole fraction of: Y2O3, BaO, or a combination of Y2O3 and BaO; and optionally Ta2O5. The sum of the Y2O3, the BaO and the optional Ta2O5 is from about 0.10 to about 0.50 mole fraction. The glass includes less than 0.01 mole fraction of Na2O and less than 0.01 mole fraction of K2O. The glass material may be in the form of microspheres. The microspheres may be used for vascular embolization and/or radiologic imaging.

Abstract: The present disclosure provides a composition that includes a mixture of (i) radioactive microparticles; and (ii) non-radioactive microparticles. The radioactive microparticles may be suitable to treat a vascularized tumour, such as a liver tumour or a metastasized liver tumour. The radioactive microparticles and the non-radioactive microparticles may have substantially the same resistance when flowing in a liquid through a conduit. The present disclosure also provides methods of making and methods of using mixtures of microparticles.

Abstract: A glass material that includes: from about 0.55 to about 0.85 mole fraction of SiO2; from about 0.01 to about 0.23 mole fraction of Na2O, K2O, or a combination of Na2O and K2O; from about 0.05 to about 0.28 mole fraction of: Y2O3, BaO, or a combination of Y2O3 and BaO; and optionally Ta2O5. In the glass material, the sum of the Y2O3, the BaO and the optional Ta2O5 is from about 0.10 to about 0.31 mole fraction. The glass material may be in the form of microspheres. The microspheres may be used for vascular embolization and/or radiologic imaging.

Abstract: At least one embodiment of an ultrasonic periodontal probe, the ultrasonic periodontal probe comprising a grip portion having a longitudinal axis, a support member comprising a part having a longitudinal axis different from the longitudinal axis of the grip portion, and an ultrasonic device fastened to the grip portion via the support member, wherein the ultrasonic device is configured for emitting ultrasound signals within at least two emitting cones and for receiving corresponding echoed ultrasound signals, the at least two emitting cones extending in opposite directions with regard to a plane comprising the longitudinal axis of the grip portion.

Abstract: This invention concerns an ultrasonic dental imaging probe (1), typically comprising several transducers (4) arranged to operate as a transmitter and a receiver, and in particular arranged to transmit ultrasonic waves at a frequency of at least 10 MHz, and optionally several transducers (4) arranged to operate as a transmitter and a receiver and arranged to transmit ultrasonic waves at a frequency of less than 4 MHz. The transducers are mounted on a flexible support (3), secured to a rigid frame (2) typically in a “U” shape. The invention also concerns a device comprising one such probe.

Abstract: The invention relates to a genetically modified infectious measles virus derived from a live-attenuated measles virus strain, in which the gene encoding the viral accessory C protein has been knocked out (MV-deltaC). It concerns in particular the use of said genetically modified infectious MV-deltaC in the treatment of malignant tumour or cancer conditions, and for the preparation of agents or compositions for such treatment.

Abstract: The invention relates to a genetically modified infectious measles virus derived from a live-attenuated measles virus strain, in which the gene encoding the viral accessory C protein has been knocked out (MV-deltaC). It concerns in particular the use of said genetically modified infectious MV-deltaC in the treatment of malignant tumour or cancer conditions, and for the preparation of agents or compositions for such treatment.

Abstract: The invention relates to a genetically modified infectious measles virus derived from a live-attenuated measles virus strain, in which the gene encoding the viral accessory C protein has been knocked out (MV-deltaC). It concerns in particular the use of said genetically modified infectious MV-deltaC in the treatment of malignant tumor or cancer conditions, and for the preparation of agents or compositions for such treatment.

Abstract: The invention relates to a genetically modified infectious measles virus derived from a live-attenuated measles virus strain, in which the gene encoding the viral accessory C protein has been knocked out (MV-deltaC). It concerns in particular the use of said genetically modified infectious MV-deltaC in the treatment of malignant tumour or cancer conditions, and for the preparation of agents or compositions for such treatment.

Abstract: The invention relates to a genetically modified infectious measles virus derived from a live-attenuated measles virus strain, in which the gene encoding the viral accessory C protein has been knocked out (MV-deltaC). It concerns in particular the use of said genetically modified infectious MV-deltaC in the treatment of malignant tumor or cancer conditions, and for the preparation of agents or compositions for such treatment.

Abstract: The present invention relates to the use of at least one attenuated measles virus for the manufacture of a medicament intended for treating malignant mesothelioma in an individual.

Abstract: The invention relates to a genetically modified infectious measles virus derived from a live-attenuated measles virus strain, in which the gene encoding the viral accessory C protein has been knocked out (MV-deltaC). It concerns in particular the use of said genetically modified infectious MV-deltaC in the treatment of malignant tumour or cancer conditions, and for the preparation of agents or compositions for such treatment.

Abstract: This invention concerns an ultrasonic dental imaging probe (1), typically comprising several transducers (4) arranged to operate as a transmitter and a receiver, and in particular arranged to transmit ultrasonic waves at a frequency of at least 10 MHz, and optionally several transducers (4) arranged to operate as a transmitter and a receiver and arranged to transmit ultrasonic waves at a frequency of less than 4 MHz. The transducers are mounted on a flexible support (3), secured to a rigid frame (2) typically in a “U” shape. The invention also concerns a device comprising one such probe.

Abstract: The present invention relates to the use of at least one attenuated measles virus for the manufacture of a medicament intended for treating malignant mesothelioma in an individual.

Abstract: The present invention relates to the use of at least one attenuated measles virus for the manufacture of a medicament intended for treating malignant mesothelioma in an individual.

Abstract: Novel polymer nanovectors or particles and use thereof as medication and/or diagnostic agents.

Abstract: The present invention relates to the use of at least one attenuated measles virus for the manufacture of a medicament intended for treating malignant mesothelioma in an individual.

Abstract: The present invention relates to apoptotic bodies derived from human tumor cells or cell lines recovered from patient's tumor biopsy and induced to apoptotis, said apoptotic bodies having the following characteristics: they maintain plasma membrane integrity, they are vesicles above about 0,1 &mgr;m, they contain intact mitochondria and cleaved nuclear DNA originating from the tumor cells, they present unmasked tumor antigens on their membranes, they present specific tumor and MHC antigens from the patient. The invention also provides new monocytes derived cells, which can be used as anti-tumor vaccines after integration of apoptotic bodies. Apoptotic bodies are phagocytosed and processed by monocyte derived antigen presenting cells and potentiate the effective tumor antigenic presentation to the immune system.

Abstract: A probe including a body having a main chamber receiving an assembly for transmitting and receiving an ultrasonic wave. The assembly is mounted on a frame driven in reciprocating motion by a driving motor. The chamber is closed by a probe tip having a slot made of a liquid impermeable solid element which is permeable to the acoustic wave transmitted by the acoustic transducer and toward the acoustic transducer. A reciprocating motion of the acoustic transducer is a translating movement parallel to the slot such that the ultrasonic beam is normal at the slot.